Patient Characteristics
| Disease . | Stage . | No. of Patients Studied . | No. of Patients Treated . | Stem Cell Source (allogeneic/autologous) . |
|---|---|---|---|---|
| AML | All stages | 31 | 22 | 14/8 |
| 1° refractory | 4 | 2 | 2/0 | |
| Untreated first relapse | 13 | 9 | 5/4 | |
| Refractory first relapse | 2 | 2 | 2/0 | |
| Second remission | 8 | 6 | 2/4 | |
| Second relapse | 3 | 2 | 2/0 | |
| Third remission | 1 | 1 | 1/0 | |
| MDS | RAEB | 2 | 2 | 2/0 |
| RAEBT | 1 | 1 | 1/0 | |
| ALL | All stages | 10 | 9 | 6/3 |
| 1° refractory | 3 | 3 | 3/0 | |
| Second remission | 4 | 4 | 1/3 | |
| Refractory relapse | 2 | 2 | 2/0 | |
| Third remission | 1 | 0 | 0/0 |
| Disease . | Stage . | No. of Patients Studied . | No. of Patients Treated . | Stem Cell Source (allogeneic/autologous) . |
|---|---|---|---|---|
| AML | All stages | 31 | 22 | 14/8 |
| 1° refractory | 4 | 2 | 2/0 | |
| Untreated first relapse | 13 | 9 | 5/4 | |
| Refractory first relapse | 2 | 2 | 2/0 | |
| Second remission | 8 | 6 | 2/4 | |
| Second relapse | 3 | 2 | 2/0 | |
| Third remission | 1 | 1 | 1/0 | |
| MDS | RAEB | 2 | 2 | 2/0 |
| RAEBT | 1 | 1 | 1/0 | |
| ALL | All stages | 10 | 9 | 6/3 |
| 1° refractory | 3 | 3 | 3/0 | |
| Second remission | 4 | 4 | 1/3 | |
| Refractory relapse | 2 | 2 | 2/0 | |
| Third remission | 1 | 0 | 0/0 |